[Prenatal diagnosis and prevalence of Down syndrome in the Parisian population, 2001-2005].
暂无分享,去创建一个
F. Goffinet | B. Khoshnood | C. de Vigan | B Khoshnood | F Goffinet | C de Vigan | E Cadio | V Vodovar | V. Vodovar | E. Cadio
[1] F. Goffinet,et al. Iconography : Prévalence et diagnostic prénatal des malformations en population parisienne , 2008 .
[2] B. Blondel,et al. Effects of maternal age and education on the pattern of prenatal testing: implications for the use of antenatal screening as a solution to the growing number of amniocenteses. , 2003, American journal of obstetrics and gynecology.
[3] T. Marteau. Towards informed decisions about prenatal testing: A review , 1995, Prenatal diagnosis.
[4] F. Goffinet,et al. Advances in medical technology and creation of disparities: the case of Down syndrome. , 2006, American journal of public health.
[5] A. Rudnicka,et al. First-trimester or second-trimester screening, or both, for Down's syndrome. , 2005, The New England journal of medicine.
[6] F. Bianchi,et al. Trends and geographic inequalities in the prevalence of Down syndrome in Europe, 1980-1999. , 2005, Revue d'epidemiologie et de sante publique.
[7] J. Goujard. La mesure de la clarté nucale et le dosage des marqueurs sériques commencent-ils à modifier l'incidence de la trisomie 21 en France ? , 2004 .
[8] F. Malone,et al. Integrated screening for Down's syndrome. , 1999, The New England journal of medicine.
[9] R. Snijders,et al. First-trimester screening for trisomies 21 and 18 , 2003 .
[10] T. Marteau,et al. Prenatal testing: towards realistic expectations of patients, providers and policy makers , 2002, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[11] F. Goffinet,et al. A population‐based evaluation of the impact of antenatal screening for Down's syndrome in France, 1981–2000 , 2004, BJOG: an International Journal of Obstetrics and Gynaecology.